Aug 18 (Reuters) – T. Rowe Price Group Inc has sued
Valeant Pharmaceuticals International Inc ,
alleging that investors in the Canadian drugmaker lost billions
of dollars as a result of the company’s…
The post UPDATE 1-T. Rowe Price sues Valeant over “fraudulent scheme” appeared first on NASDAQ.